Everolimus-Eluting Stent for Bifurcation Coronary Lesions: Comparison of Simple Versus Complex Techniques

NCT00916695 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

332

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: Xience V Everolimus Eluting Coronary Stent System. Abbott Laboratories. Abbott Park, Illinois, U.S.A.

Sponsor

Spanish Society of Cardiology